210 related articles for article (PubMed ID: 9921972)
1. A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis.
Laccourreye O; Diaz EM; Bassot V; Muscatello L; Garcia D; Brasnu D
Cancer; 1999 Jan; 85(1):40-6. PubMed ID: 9921972
[TBL] [Abstract][Full Text] [Related]
2. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
[TBL] [Abstract][Full Text] [Related]
3. Local recurrence after vertical partial laryngectomy, a conservative modality of treatment for patients with Stage I-II squamous cell carcinoma of the glottis.
Laccourreye O; Gutierrez-Fonseca R; Garcia D; Hans S; Hacquart N; Ménard M; Brasnu D
Cancer; 1999 Jun; 85(12):2549-56. PubMed ID: 10375101
[TBL] [Abstract][Full Text] [Related]
4. [Cisplatin-fluorouracil chemotherapy in epidermoid cancers of glottic origin staged as T2].
Laccourreye O; Bassot V; Naudo P; Jouffre V; Brasnu D; Laccourreye H
Ann Otolaryngol Chir Cervicofac; 1994; 111(5):281-91. PubMed ID: 7755306
[TBL] [Abstract][Full Text] [Related]
5. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
[TBL] [Abstract][Full Text] [Related]
6. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
7. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
8. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM
Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214
[TBL] [Abstract][Full Text] [Related]
10. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
[TBL] [Abstract][Full Text] [Related]
11. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
12. CO2 laser treatment of supraglottic cancer.
Motta G; Esposito E; Testa D; Iovine R; Motta S
Head Neck; 2004 May; 26(5):442-6. PubMed ID: 15122661
[TBL] [Abstract][Full Text] [Related]
13. Predictors of local failure in early laryngeal cancer.
Lohynska R; Slavicek A; Bahanan A; Novakova P
Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
[TBL] [Abstract][Full Text] [Related]
14. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
[TBL] [Abstract][Full Text] [Related]
16. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis: concurrent chemoradiotherapy and adjuvant chemotherapy for T2N0 glottic squamous cell carcinoma.
Nonoshita T; Shioyama Y; Kunitake N; Nakamura K; Nomoto S; Ohga S; Toriya Y; Ono M; Honda H
Fukuoka Igaku Zasshi; 2009 Jan; 100(1):26-31. PubMed ID: 19378773
[TBL] [Abstract][Full Text] [Related]
18. CO(2) laser surgery in the treatment of glottic cancer.
Motta G; Esposito E; Motta S; Tartaro G; Testa D
Head Neck; 2005 Jul; 27(7):566-73; discussion 573-4. PubMed ID: 15898101
[TBL] [Abstract][Full Text] [Related]
19. A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2.
Laccourreye O; Weinstein G; Brasnu D; Bassot V; Cauchois R; Jouffre V; Garcia D; Laccourreye H
Cancer; 1994 Nov; 74(10):2781-90. PubMed ID: 7954237
[TBL] [Abstract][Full Text] [Related]
20. Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?
Solares CA; Wood B; Rodriguez CP; Lorenz RR; Scharpf J; Saxton J; Rybicki LA; Strome M; Esclamado R; Lavertu P; Adelstein DJ
Laryngoscope; 2009 Jun; 119(6):1130-4. PubMed ID: 19358250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]